BMO Capital Downgrades TrueBlue (TBI) to Market Perform

February 5, 2016 7:09 AM

BMO Capital downgraded TrueBlue (NYSE: TBI) from Outperform to Market Perform with a price target of $26.00 (from $35.00).

For an analyst ratings summary and ratings history on TrueBlue click here. For more ratings news on TrueBlue click here.